Cite
APA Citation
Seufferlein, T., Lausser, L., Stein, A., Prager, G., Kasper, S., Niedermeier, M., Müller, L., Kubicka, S., König, A., Büchner-Steudel, P., Wille, K., Perkhofer, L., Hann, A., Berger, A. W., Arnold, D., Kestler, H., & Ettrich, T. J. (n.d.). 474PA novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab: First results of the PERMAD trial. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095320852.0x000038